Evaxion Biotech A/S ( EVAX) - Key Metrics
EVAX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $0 | -$0.44 | $0 | $0 |
| 2025Q4 | $0 | -$0.92 | $0 | $0 |
| 2025Q3 | $6.78 | $4.18 | $0 | $0 |
| 2025Q2 | $0.03 | -$4.37 | $0 | $0 |
| 2025Q1 | $0 | -$1.43 | $0 | $0 |
EVAX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 0% | -2.11 |
| 2025Q4 | 0% | -1.34 |
| 2025Q3 | 0% | 0.22 |
| 2025Q2 | 0% | -0.14 |
| 2025Q1 | 0% | -0.32 |
EVAX
Price: $3.07
52 week price:
Earnings Per Share: -1.01 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Denmark
Volume: 302177
Market Capitalization: 20.2 million